The bill, which prohibits the Alabama Board of Medical Examiners and the Medical Licensure Commission of Alabama from taking action, passed unanimously in the state House and Legislature.
Off-label use refers to prescribing an approved drug for an unapproved disease or condition, administering it in a different form or giving it in a different dose.